Celgene Corp (CELG-Q) Stock Predictions - Stockchase
WATCH LIST
75
Celgene Corp (CELG-Q)

ON STOCKCHASE SINCE Jan 2012

Consumer Products

Celgene Corp Celgene Corp
CELG-Q

14 75
Consumer Products

Celgene Corp (CELG-Q) SAVE

87.72

0.58 (0.66%)

Sep, 22, 2018, 12:00 am

OPINIONS

About Celgene Corp (CELG-Q)

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. More at Wikipedia

What the experts are saying about CELG-Q



  • All
  • Filtered
Signal Opinion Expert
DON'T BUY
Celgene Corp(CELG-Q) 

September 18, 2018

They were working on some drug trials which didn't work as expected. Acqusitions didnt work out either The balance sheet is weaker than before. Some of their drugs will soon lose their patent.

Consumer Products

They were working on some drug trials which didn't work as expected. Acqusitions didnt work out either The balance sheet is weaker than before. Some of their drugs will soon lose their patent.

Consumer Products
John O'Connell,

Chairman a, Davis Rea...

Price Price
$87.610
Owned Owned
No

HOLD
Celgene Corp(CELG-Q) 

September 12, 2018

Stock price has pushed up above the 200-day moving average. Longer term, this is an important space to be in. Good pipeline. Hold onto it at this point. Valuation is cheap. Trading at 9x earnings, expected 20% growth rate.

Consumer Products

Stock price has pushed up above the 200-day moving average. Longer term, this is an important space to be in. Good pipeline. Hold onto it at this point. Valuation is cheap. Trading at 9x earnings, expected 20% growth rate.

Consumer Products
Stan Wong

Director &, Private Wealth Manag...

Price Price
$86.800
Owned Owned
No

PAST TOP PICK
Celgene Corp(CELG-Q) 

August 21, 2018

(A Top Pick September 19, 2017. Down 37%). About 70% of the stocks he buys turn into gains. Celgene was one of the losses. Generally, the goal is to cut losses quickly. However, Celgene’s earnings have been rising, not falling. The difference is that the market has lost confidence in the company and dropped the valuation from a premium level to an extreme discount. The company has had some missteps, failed drug trials, that pare down its long term growth. Looking at Celgene at today’s price, he is keeping it because it offers good value at this price.

Consumer Products

(A Top Pick September 19, 2017. Down 37%). About 70% of the stocks he buys turn into gains. Celgene was one of the losses. Generally, the goal is to cut losses quickly. However, Celgene’s earnings have been rising, not falling. The difference is that the market has lost confidence in the company and dropped the valuation from a premium level to an extreme discount. The company has had some missteps, failed drug trials, that pare down its long term growth. Looking at Celgene at today’s price, he is keeping it because it offers good value at this price.

Consumer Products
Gordon Reid

President, GoodReid Investment ...

Price Price
$91.200
Owned Owned
Yes

PARTIAL BUY
Celgene Corp(CELG-Q) 

July 27, 2018

Nice chart. Really nice base in May/June around $79. If it can stay above $83, it’s looking pretty good. Potential to consolidate around $100, as an end of year target. If it drops another $8, start reducing. Take a small position only.

Consumer Products

Nice chart. Really nice base in May/June around $79. If it can stay above $83, it’s looking pretty good. Potential to consolidate around $100, as an end of year target. If it drops another $8, start reducing. Take a small position only.

Consumer Products
Jeff Parent B.

VP & Portf, Castlemoore Inc....

Price Price
$86.430
Owned Owned
Unknown

DON'T BUY
Celgene Corp(CELG-Q) 

July 18, 2018

The biotech sector is performing well.  He would prefer to own the XBI-N ETF to get a basket and diversify risk.  

Consumer Products

The biotech sector is performing well.  He would prefer to own the XBI-N ETF to get a basket and diversify risk.  

Consumer Products
David Burrows

President , Barometer Capital Ma...

Price Price
$85.780
Owned Owned
No

PARTIAL BUY
Celgene Corp(CELG-Q) 

July 9, 2018

It is turning around.  It got hammered and is showing some potential.  It looks like it is breaking the downtrend.  He is keeping a sharp eye on it.  He is optimistic.

Consumer Products

It is turning around.  It got hammered and is showing some potential.  It looks like it is breaking the downtrend.  He is keeping a sharp eye on it.  He is optimistic.

Consumer Products
Keith Richards

Portfolio , ValueTrend Wealth Ma...

Price Price
$83.850
Owned Owned
Yes

HOLD
Celgene Corp(CELG-Q) 

July 5, 2018

Own widely. They had a number of missteps. They reduced their guidance. Great valuation. Some competitive threads coming in 2021-22. He would be cautious. (Analysts’ price target is $113.68)

Consumer Products

Own widely. They had a number of missteps. They reduced their guidance. Great valuation. Some competitive threads coming in 2021-22. He would be cautious. (Analysts’ price target is $113.68)

Consumer Products
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$80.390
Owned Owned
No

WATCH
Celgene Corp(CELG-Q) 

June 20, 2018

He has started watching this bio-tech company as their earnings have been improving.  The technical chart looks bearish to him now.  He will watch them.  (Analysts’ price target is $114)

Consumer Products

He has started watching this bio-tech company as their earnings have been improving.  The technical chart looks bearish to him now.  He will watch them.  (Analysts’ price target is $114)

Consumer Products
Jason Del Vicar

Portfolio , HollisWealth...

Price Price
$79.770
Owned Owned
No

BUY
Celgene Corp(CELG-Q) 

June 14, 2018

This sector is fragmented and under valued. He likes it but has some short term issues that have hurt the stock.  This is a negative momentum stock. Expects this to be higher in a year or 2. His favourite is Gilead in the sector.  

Consumer Products

This sector is fragmented and under valued. He likes it but has some short term issues that have hurt the stock.  This is a negative momentum stock. Expects this to be higher in a year or 2. His favourite is Gilead in the sector.  

Consumer Products
Alex Ruus

Portfolio , Arrow Capital Manage...

Price Price
$78.390
Owned Owned
Unknown

TOP PICK
Celgene Corp(CELG-Q) 

May 30, 2018

He's long owned this. They has a nasty surprise in 2017 when a drug failed to get approval, plus other issues. Currently it's selling at 9x earnings. Firmly believe their new products--with big upside--will carry this company higher. (Analysts' price target: $111.83)

Consumer Products

He's long owned this. They has a nasty surprise in 2017 when a drug failed to get approval, plus other issues. Currently it's selling at 9x earnings. Firmly believe their new products--with big upside--will carry this company higher. (Analysts' price target: $111.83)

Consumer Products
Bruce Murray

CEO & Chie, The Murray Wealth Gr...

Price Price
$77.970
Owned Owned
Yes

PAST TOP PICK
Celgene Corp(CELG-Q) 

May 28, 2018

(A Top Pick May 28/17, Down 32%)  It is considered best of class but stumbled and there is a negative sentiment to health care stocks.  It is growing double digits but trading at a single digit multiple so he is just holding it for now.

Consumer Products

(A Top Pick May 28/17, Down 32%)  It is considered best of class but stumbled and there is a negative sentiment to health care stocks.  It is growing double digits but trading at a single digit multiple so he is just holding it for now.

Consumer Products
Teal Linde

Portfolio , Linde Equity Report...

Price Price
$78.630
Owned Owned
Yes

DON'T BUY
Celgene Corp(CELG-Q) 

May 28, 2018

Not cheap, based on its historic valuation. Fundamentally, it's a good business, but its chart is unhealthy. Healthcare should be in any portfolio and this is a quality company. But Celgene ranks near the bottom of his medical/health stocks, 45 out of 49.

Consumer Products

Not cheap, based on its historic valuation. Fundamentally, it's a good business, but its chart is unhealthy. Healthcare should be in any portfolio and this is a quality company. But Celgene ranks near the bottom of his medical/health stocks, 45 out of 49.

Consumer Products
Wolfgang Klein

Senior inv, Canaccord Genuity We...

Price Price
$78.630
Owned Owned
No

DON'T BUY
Celgene Corp(CELG-Q) 

May 24, 2018

Sold it a while ago. Looks cheap from a valuation standpoint trading at 9 times forward earning with a 19% growth rate. Investors are concerned about their cancer drugs patents expiring in a couple of years. Dark cloud surrounding the company.

Consumer Products

Sold it a while ago. Looks cheap from a valuation standpoint trading at 9 times forward earning with a 19% growth rate. Investors are concerned about their cancer drugs patents expiring in a couple of years. Dark cloud surrounding the company.

Consumer Products
Stan Wong

Director &, Private Wealth Manag...

Price Price
$78.630
Owned Owned
No

DON'T BUY
Celgene Corp(CELG-Q) 

May 9, 2018

They completed a $5 billion buyback recently.  They put up a beat on recent earnings, but there were concerns about future earnings.  He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum.  They have great forecasted cash flow, but watch out if they miss their guidance. 

Consumer Products

They completed a $5 billion buyback recently.  They put up a beat on recent earnings, but there were concerns about future earnings.  He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum.  They have great forecasted cash flow, but watch out if they miss their guidance. 

Consumer Products
Cameron Hurst

Chief Inve, Equium Capital Manag...

Price Price
$82.800
Owned Owned
No

BUY
Celgene Corp(CELG-Q) 

April 30, 2018

We have some erosion here.  You have to live with the overreaction.  Around the $75 - $85 range there is probably a really good opportunity. 

Consumer Products

We have some erosion here.  You have to live with the overreaction.  Around the $75 - $85 range there is probably a really good opportunity. 

Consumer Products
Hap (Robert) Sn

Chief Port, Castlemoore Inc....

Price Price
$87.100
Owned Owned
Unknown

Showing 1 to 15 of 75 entries

No Comments.


You must be logged in to comment.

Successfully Saved Company
Successfully Saved Company